139 related articles for article (PubMed ID: 34662565)
21. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Zhang ZH; Lee YT; Rhodes K; Wang K; Argentieri TM; Wang Q
Brain Res Mol Brain Res; 2003 Jul; 115(1):29-38. PubMed ID: 12824052
[TBL] [Abstract][Full Text] [Related]
23. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property.
Ahn HS; Kim SE; Choi BH; Choi JS; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kwon OJ; Hahn SJ
Am J Physiol Cell Physiol; 2007 May; 292(5):C1714-22. PubMed ID: 17166943
[TBL] [Abstract][Full Text] [Related]
24. [Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes].
Li MW; Wang XP; Gao CY; Zou AR
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):165-8. PubMed ID: 19719998
[TBL] [Abstract][Full Text] [Related]
25. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
[TBL] [Abstract][Full Text] [Related]
26. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of human beta-defensins 3 and 4 on potassium channels: Evidence of diversity in beta-defensin-potassium channel interactions.
Zhao Y; Xie Z; Feng J; Li W; Cao Z; Wu Y
Peptides; 2018 Oct; 108():14-18. PubMed ID: 30121363
[TBL] [Abstract][Full Text] [Related]
28. Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells.
Choi JS; Hahn SJ; Rhie DJ; Jo YH; Kim MS
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):256-61. PubMed ID: 10344523
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the activity of human lymphocyte Kv1.3 potassium channels by resveratrol.
Teisseyre A; Michalak K
J Membr Biol; 2006; 214(3):123-9. PubMed ID: 17557164
[TBL] [Abstract][Full Text] [Related]
30. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
[TBL] [Abstract][Full Text] [Related]
31. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
32. Electrochemical strategy to scout 1,4-naphthoquinones effect on voltage gated potassium channels.
Rodríguez-Fernández T; Ugalde-Saldívar VM; González I; Escobar LI; García-Valdés J
Bioelectrochemistry; 2012 Aug; 86():1-8. PubMed ID: 22265102
[TBL] [Abstract][Full Text] [Related]
33. Effect of Cd2+ on Kv4.2 and Kv1.4 expressed in Xenopus oocytes and on the transient outward currents in rat and rabbit ventricular myocytes.
Wickenden AD; Tsushima RG; Losito VA; Kaprielian R; Backx PH
Cell Physiol Biochem; 1999; 9(1):11-28. PubMed ID: 10352341
[TBL] [Abstract][Full Text] [Related]
34. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
35. Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.
Fischer F; Vonderlin N; Seyler C; Zitron E; Schernus B; Katus H; Scholz E
Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):795-804. PubMed ID: 23666493
[TBL] [Abstract][Full Text] [Related]
36. New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon single action potential.
Fujii M; Hayashi K; Ohya S; Yamamura H; Imaizumi Y
J Pharmacol Sci; 2013; 123(2):147-58. PubMed ID: 24096832
[TBL] [Abstract][Full Text] [Related]
37. The selective serotonin reuptake inhibitor dapoxetine inhibits voltage-dependent K
Kim HS; Li H; Kim HW; Shin SE; Jung WK; Ha KS; Han ET; Hong SH; Firth AL; Choi IW; Park WS
Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):480-487. PubMed ID: 28058743
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of copper ions on lymphocyte Kv1.3 potassium channels.
Teisseyre A; Mozrzymas JW
J Physiol Pharmacol; 2006 Jun; 57(2):301-14. PubMed ID: 16845233
[TBL] [Abstract][Full Text] [Related]
39. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.
Fischer F; Vonderlin N; Zitron E; Seyler C; Scherer D; Becker R; Katus HA; Scholz EP
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):991-9. PubMed ID: 23832378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
